help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Thissen, J. P.
Right arrow Articles by Ketelslegers, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thissen, J. P.
Right arrow Articles by Ketelslegers, J. M.

Endocrinology, Vol 129, 429-435, Copyright © 1991 by Endocrine Society


ARTICLES

Evidence that pretranslational and translational defects decrease serum insulin-like growth factor-I concentrations during dietary protein restriction

JP Thissen, S Triest, BM Moats-Staats, LE Underwood, T Mauerhoff, D Maiter and JM Ketelslegers
Department of Pediatrics, University of North Carolina School of Medicine, Chapel Hill 27599.

Dietary protein restriction causes GH resistance and decreases serum insulin-like growth factor-I (IGF-I) concentrations. To determine whether pretranslational or translational defects are involved in the decline of serum IGF-I concentrations during protein restriction, we measured hepatic IGF-I mRNA abundance together with the serum IGF-I peptide response to exogenous GH after 1 week of protein restriction (5% casein in diet; P5) in hypophysectomized rats. We compared these responses with those of hypophysectomized rats fed a protein-sufficient diet (15% casein in diet; P15) and given exogenous GH. A single injection of rat GH (200 micrograms/100 g BW) produced a comparable IGF- I mRNA increment in both groups (at 6 h, 7.8 +/- 1.1 arbitrary units in P5 vs. 8.2 +/- 1.1 in P15), but failed to raise serum IGF-I normally in the P5 group (at 6 h, 90 +/- 15 ng/ml in P5 vs. 216 +/- 63 in P15; P less than 0.01). The post-GH decline of the 7.5-kilobase (kb) IGF-I mRNA abundance was faster in P5 than in P15 animals. In another experiment in intact rats subjected to protein restriction, injections of pharmacological doses of rat GH (400 micrograms/100 g BW.day) for 1 week restored liver IGF-I mRNA abundance to normal without normalization of serum IGF-I (403 +/- 91 vs. 713 +/- 53 ng/ml; P less than 0.01). Our data suggest that 1) the machinery involved in the transcription of the liver IGF-I gene is intact in protein-restricted rats, because these animals retain the ability to muster normal IGF-I mRNA responses to high doses of exogenous GH; 2) the stability of the 7.5-kb IGF-I mRNA is probably decreased by the protein restriction, as suggested by the faster decline of the 7.5-kb transcript in P5 than in P15 hypophysectomized rats; and 3) the discrepancy between normal liver IGF-I mRNA abundance and low serum and liver IGF-I peptide concentrations suggests that translational stalling of the IGF-I mRNAs or increased serum IGF-I clearance is involved in the low serum IGF-I concentrations during dietary protein restriction.


This article has been cited by other articles:


Home page
Am. J. Clin. Nutr.Home page
L. Fontana, S. Klein, and J. O Holloszy
Long-term low-protein, low-calorie diet and endurance exercise modulate metabolic factors associated with cancer risk
Am. J. Clinical Nutrition, December 1, 2006; 84(6): 1456 - 1462.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
O. Schakman, H. Gilson, V. de Coninck, P. Lause, J. Verniers, X. Havaux, J. M. Ketelslegers, and J. P. Thissen
Insulin-Like Growth Factor-I Gene Transfer by Electroporation Prevents Skeletal Muscle Atrophy in Glucocorticoid-Treated Rats
Endocrinology, April 1, 2005; 146(4): 1789 - 1797.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. Dehoux, R. Van Beneden, N. Pasko, P. Lause, J. Verniers, L. Underwood, J.-M. Ketelslegers, and J.-P. Thissen
Role of the Insulin-Like Growth Factor I Decline in the Induction of Atrogin-1/MAFbx during Fasting and Diabetes
Endocrinology, November 1, 2004; 145(11): 4806 - 4812.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
Y. Wang, S. Eleswarapu, W. E. Beal, W. S. Swecker Jr., R. M. Akers, and H. Jiang
Reduced Serum Insulin-Like Growth Factor (IGF) I Is Associated with Reduced Liver IGF-I mRNA and Liver Growth Hormone Receptor mRNA in Food-Deprived Cattle
J. Nutr., August 1, 2003; 133(8): 2555 - 2560.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
E. Kajantie, C. H. D. Fall, M. Seppala, R. Koistinen, L. Dunkel, H. Yliharsila, C. Osmond, S. Andersson, D. J. P. Barker, T. Forsen, et al.
Serum Insulin-like Growth Factor (IGF)-I and IGF-Binding Protein-1 in Elderly People: Relationships with Cardiovascular Risk Factors, Body Composition, Size at Birth, and Childhood Growth
J. Clin. Endocrinol. Metab., March 1, 2003; 88(3): 1059 - 1065.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S.-E. Kong, R. C. Baxter, and P. J. D. Delhanty
Age-Dependent Regulation of the Acid-Labile Subunit in Response to Fasting-Refeeding in Rats
Endocrinology, December 1, 2002; 143(12): 4505 - 4512.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
W. M. Naranjo, S. Yakar, M. Sanchez-Gomez, A. U. Perez, J. Setser, and D. LERoith
Protein Calorie Restriction Affects Nonhepatic IGF-I Production and the Lymphoid System: Studies Using the Liver-Specific IGF-I Gene-Deleted Mouse Model
Endocrinology, June 1, 2002; 143(6): 2233 - 2241.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
M. Katsumata, S. Kawakami, Y. Kaji, R. Takada, and M. J. Dauncey
Differential Regulation of Porcine Hepatic IGF-I mRNA Expression and Plasma IGF-I Concentration by a Low Lysine Diet
J. Nutr., April 1, 2002; 132(4): 688 - 692.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
S. Sheikh, P. Satoskar, and D. Bhartiya
Expression of insulin-like growth factor-I and placental growth hormone mRNA in placentae: a comparison between normal and intrauterine growth retardation pregnancies
Mol. Hum. Reprod., March 1, 2001; 7(3): 287 - 292.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A. Colson, A. Le Cam, D. Maiter, M. Edery, and J.-P. Thissen
Potentiation of Growth Hormone-Induced Liver Suppressors of Cytokine Signaling Messenger Ribonucleic Acid by Cytokines
Endocrinology, October 1, 2000; 141(10): 3687 - 3695.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
C. H. Lang, X. Liu, G. J. Nystrom, and R. A. Frost
Acute response of IGF-I and IGF binding proteins induced by thermal injury
Am J Physiol Endocrinol Metab, June 1, 2000; 278(6): E1087 - E1096.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
J. C. D. Filho, S. J. Hazel, B. Anderstam, J. Bergstrom, M. Lewitt, and K. Hall
Effect of protein intake on plasma and erythrocyte free amino acids and serum IGF-I and IGFBP-1 levels in rats
Am J Physiol Endocrinol Metab, October 1, 1999; 277(4): E693 - E701.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
V. Beauloye, S. M. Muaku, P. Lause, D. Portetelle, R. Renaville, A. R. Robert, J. M. Ketelslegers, and D. Maiter
Monoclonal antibodies to growth hormone (GH) prolong liver GH binding and GH-induced IGF-I/IGFBP-3 synthesis
Am J Physiol Endocrinol Metab, August 1, 1999; 277(2): E308 - E315.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
D. Defalque, N. Brandt, J.-M. Ketelslegers, and J.-P. Thissen
GH insensitivity induced by endotoxin injection is associated with decreased liver GH receptors
Am J Physiol Endocrinol Metab, March 1, 1999; 276(3): E565 - E572.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J. Zhang, D. Chrysis, and L. E. Underwood
Reduction of Hepatic Insulin-Like Growth Factor I (IGF-I) Messenger Ribonucleic Acid (mRNA) during Fasting Is Associated with Diminished Splicing of IGF-I Pre-mRNA and Decreased Stability of Cytoplasmic IGF-I mRNA
Endocrinology, November 1, 1998; 139(11): 4523 - 4530.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
B. Velasco, L. Cacicedo, J. Escalada, J. Lopez-Fernandez, and F. Sanchez-Franco
Growth Hormone Gene Expression and Secretion in Aging Rats Is Age Dependent and Not Age-Associated Weight Increase Related
Endocrinology, March 1, 1998; 139(3): 1314 - 1320.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J. Zhang, R. E. Whitehead Jr., and L. E. Underwood
Effect of Fasting on Insulin-Like Growth Factor (IGF)-IA and IGF-IB Messenger Ribonucleic Acids and Prehormones in Rat Liver
Endocrinology, August 1, 1997; 138(8): 3112 - 3118.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
E. Melian, B. Velasco, R. Barrios, and F. Sanchez-Franco
Basal and Growth Hormone-Induced Hepatic Messenger Ribonucleic Acid Expression of Insulin-Like Growth Factor-I (IGF-I) and IGF-Binding Protein-3 Is Independent of Hyperinsulinemia and Increased Energy Status in the Genetically Obese Zucker Rat
Endocrinology, March 1, 1997; 138(3): 1066 - 1071.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J.-P. Thissen and J. Verniers
Inhibition by Interleukin-1{beta} and Tumor Necrosis Factor-{alpha} of the Insulin-Like Growth Factor I Messenger Ribonucleic Acid Response to Growth Hormone in Rat Hepatocyte Primary Culture
Endocrinology, March 1, 1997; 138(3): 1078 - 1084.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1991 by The Endocrine Society